Suzhou Iron Technology Co. Ltd. A

688329 · SHG · Healthcare / Medical Instruments & Supplies

18.00CNY-0.47 (-2.54%)

Price History

Full chart

Market Stats

Previous Close18.47

Open18.50

Day Range17.88 – 18.88

52-Week Range15.30 – 32.01

Volume2.24M

Market Cap1.85B

P/E (TTM)140.88

Forward P/E0.00

EPS0.17

Dividend Yield1.04%

Beta0.31

50-Day Avg20.56

200-Day Avg22.95

About

Suzhou Iron Technology CO.,LTD. engages in the provision of intelligent medical material management solutions in China and internationally. The company operates through Smart Pharmacy, Smart Ward, Smart Warehousing, and Pharmaceutical Information segments. It offers drug storage and dispensing integration solutions; and automated manipulator dispensing, intelligent storage and retrieval, automated disassembly and repackaging, narcotic drugs dispensary, automated self-service medication dispensing, and automated dispensing system for blister medication, as well as narcotic drugs and category-psychotropic substances management machines. The company also provides intelligent medical supplies management cabinets, self-built building touchless sanitization systems, and hospital-wide integrated nursing solutions, as well as automatic packing machine for tablets and capsules, and integrated machine for medicine basket cleaning and disinfection. In addition, the company offers a software information management platform for medical supplies. Suzhou Iron Technology CO.,LTD. was founded in 2006 and is based in Suzhou, China.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Li Xu
Employees772
HeadquartersNo.71 XinQing Road, Suzhou, China, 215123, China
Websitehttps://www.iron-tech.cn

Leadership

Mr. Li XuChairman & GM · b. 1983
Ms. Wanfeng LiCFO & Director · b. 1978
Mr. Kai ZhuDeputy GM & Director · b. 1988
Ms. Chen YangSecretary to the Board · b. 1990
Mr. Zhao LiDeputy GM & R&D Center Manager · b. 1982
Xiaomin ZhangAccounting Supervisor

Financials

Income Statement

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	163.92M	196.05M	239.26M	291.43M	309.98M	389.32M	477.35M	363.55M	325.29M	452.49M
Growth (%)	-	+19.60%	+22.04%	+21.81%	+6.37%	+25.60%	+22.61%	-23.84%	-10.52%	+39.10%
Cost of Revenue	80.62M	89.20M	97.24M	126.19M	127.17M	157.23M	225.43M	177.69M	180.11M	224.26M
Gross Profit	83.30M	106.85M	142.01M	165.24M	182.81M	232.09M	251.92M	185.86M	145.18M	452.49M
Gross Margin	50.82%	54.50%	59.36%	56.70%	58.97%	59.61%	52.77%	51.12%	44.63%	100.00%
Operating Expense	70.63M	64.67M	85.98M	101.17M	102.25M	122.47M	135.63M	151.16M	169.62M	435.69M
Operating Income	12.67M	42.18M	56.04M	64.07M	80.55M	109.62M	116.29M	34.69M	-24.45M	16.80M
Operating Margin	7.73%	21.51%	23.42%	21.98%	25.99%	28.16%	24.36%	9.54%	-7.52%	3.71%
EBITDA	43.49M	65.16M	75.75M	82.34M	99.90M	129.05M	135.83M	56.22M	7.57M	42.14M
EBITDA Margin	26.53%	33.23%	31.66%	28.26%	32.23%	33.15%	28.45%	15.46%	2.33%	9.31%
Net Income	21.62M	39.88M	51.13M	53.56M	71.66M	95.59M	101.99M	29.52M	-21.70M	18.89M
Net Income Margin	13.19%	20.34%	21.37%	18.38%	23.12%	24.55%	21.37%	8.12%	-6.67%	4.17%
R&D	15.36M	20.16M	20.30M	23.25M	32.24M	39.61M	45.14M	55.20M	57.87M	60.07M
R&D as % of Total Revenue	9.37%	10.28%	8.49%	7.98%	10.40%	10.17%	9.46%	15.18%	17.79%	13.28%
Interest Expense	5.07M	3.91M	670.90K	3.24M	4.00M	3.15M	4.47M	7.05M	6.92M	6.78M
Interest Expense % of Total Revenue	3.09%	1.99%	0.28%	1.11%	1.29%	0.81%	0.94%	1.94%	2.13%	1.50%

Balance Sheet

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	384.81M	432.86M	531.32M	598.21M	795.96M	1.14B	1.41B	1.44B	1.38B	1.39B
Total Liabilities	209.31M	109.12M	167.08M	180.54M	336.47M	332.55M	563.79M	640.41M	611.45M	584.84M
Total Equity	175.40M	323.28M	360.06M	412.63M	455.53M	803.13M	838.14M	797.62M	753.01M	782.24M
Cash	36.12M	45.51M	76.62M	70.46M	172.47M	152.21M	217.99M	125.44M	140.32M	123.00M
Total Debt	126.02M	50.00M	75.90M	57.22M	131.10M	76.53M	197.33M	219.91M	201.52M	-
Net Debt	89.90M	4.49M	-721.42K	-13.24M	-41.37M	-75.68M	-20.66M	94.47M	61.19M	52.43M

Cash Flow

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-11.92M	21.82M	42.78M	54.30M	117.24M	39.75M	102.72M	89.81M	99.47M	133.33M
Investing Cash Flow	-16.29M	-35.13M	-20.32M	-44.54M	-62.40M	-249.95M	-88.48M	-161.85M	-36.74M	-
Financing Cash Flow	49.25M	27.06M	8.80M	-19.98M	40.47M	198.62M	50.06M	-22.08M	-44.36M	-
Capital Expenditure	13.91M	27.37M	15.35M	44.97M	62.51M	84.83M	101.40M	72.73M	38.73M	62.63M
Free Cash Flow	-25.83M	-5.55M	27.44M	9.33M	54.73M	-45.08M	1.31M	17.08M	60.74M	70.70M
Dividends Paid	5.00M	16.95M	14.73M	2.75M	28.95M	23.16M	38.60M	43.47M	17.97M	6.83M
FCF to OCF	216.71%	-25.43%	64.13%	17.19%	46.68%	-113.41%	1.28%	19.02%	61.07%	53.03%
Dividend Paid to FCF	-19.36%	-305.46%	53.67%	29.42%	52.89%	-51.37%	2936.60%	254.49%	29.58%	9.66%

Earnings

Report Date	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.08	0.16	0.27	0.72	-0.01	0.40	0.40	0.54	0.03	0.33
Surprise	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.85B

Enterprise Value1.86B

Trailing P/E140.88

Forward P/E0.00

Price / Sales3.72

Price / Book2.32

EPS0.17

Book Value9.77

Revenue (TTM)497.13M

Gross Profit (TTM)240.11M

EBITDA30.33M

Profit Margin2.61%

Operating Margin9.18%

Return on Equity1.77%

Return on Assets0.22%

Shares Outstanding77.20M

Shares Float44.40M

Beta0.31

Dividend Yield1.04%

Dividend Rate0.25

Payout Ratio147.12%

Dividends

20261×

0.25Jun 29, 2026

20241×

0.15Jul 5, 2024

20231×

0.50Jun 12, 2023

20221×

0.50Jun 30, 2022

20211×

0.30Jun 9, 2021